Mid cap News

Over 80% of Armada shareholders chose to redeem their shares for cash, removing nearly $195.3 million from the deal.

Goldman’s bullish case cites fast delivery growth, premium margins and a potential profit and free-cash-flow turnaround through the rest of 2026.

Consumer ETFs recovered after several weeks of losses, led by gains in Planet Fitness, MercadoLibre and Genius Sports. Meanwhile, weak delivery figures and lower price targets pressured Lucid, Polestar and Levi Strauss.

Morningstar sees room for food, beverage and household product stocks to rise as companies adjust to consumers spending less.

The FCC granted AST a 30-day authorization, from Oct.9 to Nov.8, to test radiolocation capabilities in the 902-928 MHz band over the contiguous U.S. and Hawaii.

JNJ reports third-quarter results on Tuesday, and Koyfin analysts expect modest revenue growth and lower earnings.

The ASH meeting runs Dec. 12-Dec. 15 in New Orleans. Sellas is listed at Booth 138, and more than 275 exhibitors are expected.

During an interview with CNBC, Bernstein’s Madison Rezaei highlighted a potentially unexpected group of winners, which are the companies that own the towers supporting America's cellular networks.

The trades put some of Ark's better-known holdings on the sell side, including AMD, Alphabet, and SpaceX, while its genomics-focused ARK Genomic Revolution ETF continued to add to biotech companies.

Analysts this week highlighted growth opportunities in artificial intelligence, concerns about consumer spending, and challenges facing established brands.

Bitdeer has secured a 10-year Malaysian data center deal, lifting capacity to 273.5 MW.

AST SpaceMobile completed a Telus network integration test and received U.S.-Japan recognition, but faced competitive pressure from SpaceX’s spectrum deal.

Barclays upgraded Archer Aviation to ‘Overweight’ from ‘Equal Weight’.

SpaceX’s Starlink and upcoming StarMind deployments could create an opening for Rocket Lab if Neutron delivers.

Challenges across telecommunications, electric vehicles and building products weighed on investor sentiment.

Munich became Nio’s only remaining German hub after its Cologne and Weiterstadt locations closed last month.

Satellite communications and spectrum consultant Tim Farrar flagged Viasat as the last available holder of a substantial block of global spectrum.

The initiative aligns with Soon-Shiong’s ‘Immunotherapy 2.0’ vision, combining immune treatments, diagnostics and monitoring to help prevent cancer recurrence.

Nio completed a record 183,664 battery swaps on Monday, surpassing its Oct.1 peak.

ARK Invest bought millions of dollars worth of Kratos and AeroVironment shares, increasing its drone investments as the Pentagon pushes ahead with autonomous warfare plans.

New product and operations leaders aim to boost Lululemon’s innovation and strengthen its connection with customers.

New Glenn’s seven-meter fairing could enable larger BlueBird batches under AST’s multi-launch agreement with Blue Origin.

Goldman Sachs said crypto revenue estimates were inflecting higher for the first time since Q4 of 2025.

Lake Street has started covering RUM with a $25 price target, citing the company’s AI infrastructure pivot.

The higher forecast arrived a week after an Israeli regulator closed its review of a filing tied to the $4.2 billion takeover.

ARK Invest bought 2.56 million Archer shares and 753,000 Joby shares, investing $16.2 million.

Retail sentiment around Aptiv turned bearish as shares remained down 31% year-to-date.

Investors will focus on Constellation’s beer sales, profit margins, and full-year outlook in Tuesday’s earnings report.

His warning followed a record Nasdaq close, while Stocktwits sentiment for SPY, QQQ and DIA was ‘extremely bullish.’

Weak housing demand and shifting investor preferences pressure the sector.

Michael Burry sold Lululemon to harvest tax losses and bought Deckers as a temporary proxy.

The U.S. and Japan highlighted AST’s Rakuten partnership in a tech cooperation statement, while William Blair cut its 2027 revenue forecast over launch delays.

No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.

Despite a sharp stock drop, retail sentiment around Sphere Entertainment has improved.

Redwire wins an Axiom Space contract for two solar arrays on its second station module.

Twist’s Lilly agreement and involvement in Anthropic research highlight its role in building and testing AI-designed proteins.

Consumer stocks struggled as sector ETFs extended losses, but Carnival, Mattel and Stitch Fix rallied on strong bookings, takeover interest and an analyst upgrade.

Nio had added 482 swap stations this year as of Friday, leaving 518 to meet its 2026 expansion target.

T-Mobile apparently removed Starlink’s name from its main T-Satellite consumer page but has not announced a change in satellite providers.

Investors focused on Nike’s turnaround struggles, Nio’s EV competition and AppLovin’s legal setback involving Unity.

Rocket, RegenXBio, Precision BioSciences, Kyverna and uniQure will present on Monday at a cell and gene-therapy conference.

Founder Patrick Soon-Shiong outlined an ‘Immunotherapy 2.0’ approach aimed at strengthening immune defenses and preventing cancer recurrence.

IO Fund highlighted Oracle’s Project Jupiter in New Mexico as a case study, arguing that securing power is no longer enough.

The changes reflect new views on restaurant demand, retail traffic, travel growth, drug risks and competition in financial data.

GameStop director Turner Nat purchases 10,462 shares.

Moderna will replace Warner Bros. Discovery in the Nasdaq-100 before markets open on Oct.9.

Mattel retail traders remain extremely bullish, expecting higher bids after Authentic Brands’ $20 per share offer.

Fresh filings named Wayne Thorsen as AST SpaceMobile’s new commercial chief and disclosed a 200,000-RSU award.

Burry cited an 1880 account of reasoning before written language to challenge whether language models can achieve genuine understanding.

Retail investors speculated that Sellas’ office lease through September 2027 provides stability for clinical results and potential deal discussions.